You are here: Industry Insights > Market News > Chinese mainland reports 39 locally transmitted COVID-19 cases

Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!

Note: You can unsubscribe from the alerts at any time.

Advertising

New Products

Riociguat(625115-55-1)

Methyl [4,6-diaMino-2-[1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl]pyriMidin-5-yl]carbaMate

2-[1-(2-Fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl]pyriMidine-4,5,6-triaMine(428854-24-4)

4,6-PyriMidinediaMine, 2-[1-[(2-fluorophenyl)Methyl]-1H-pyrazolo[3,4-b]pyridin-3-yl]-5-(phenylazo)-

1H-Pyrazolo[3,4-b]pyridine-3-carboximidamide, 1-[(2-fluorophenyl)methyl]-, hydrochloride (1:1)

1-(2-Fluorobenzyl)-1H-pyrazolo[3,4-b]pyridine-3-carboximidamide(256376-68-8)

Chinese mainland reports 39 locally transmitted COVID-19 cases

NMPANovember 10, 2021

Tag: COVID-19 , mainland , imported cases

Favorites

BEIJING -- The Chinese mainland on Tuesday reported 39 new locally transmitted COVID-19 cases, the National Health Commission said in its daily report on Nov 10.

Of the new local cases, 17 were reported in Liaoning, eight in Henan, five in Hebei, four in Heilongjiang, two each in Jiangxi and Yunnan, and one in Sichuan.

Also reported were 15 new imported cases, according to the commission.

One new suspected case arriving from outside the mainland was reported in Shanghai, and no new deaths related to COVID-19 were reported on Tuesday, said the commission.

Previous:Exploiting Real-World Data to Optimize the Use of Antibiotics

Next:Chinese mainland reports 43 locally transmitted COVID-19 cases

Corvia Medical Achieves CE Certification for Atrial Shunt Under New EU MDR Standards

PRNewswireDecember 21, 2024

Corvia Medical, Inc.announced today that it has achieved CE certification for the Corvia® Atrial Shunt System under the latest EU Medical Device Regulations (EU MDR 2017/745).

Macrogen Consortium win tender for National Bio Big Data Project

PRNewswireDecember 23, 2024

SCG Cell Therapy partners A*STAR to accelerate RNA-based therapeutic development in Singapore

PRNewswireDecember 23, 2024

Chinese mainland reports 39 locally transmitted COVID-19 cases | Pharmasources.com

Everest Medicines Announces Acceptance of the New Drug Application for VELSIPITY

Everest Medicines LimitedDecember 20, 2024

Everest Medicines announced NMPA acceptance of NDA for VELSIPITY(R) (etrasimod) to treat moderately to severely active UC.

Chinese mainland reports 39 locally transmitted COVID-19 cases

Related News

Corvia Medical Achieves CE Certification for Atrial Shunt Under New EU MDR Standards

Macrogen Consortium win tender for National Bio Big Data Project

SCG Cell Therapy partners A*STAR to accelerate RNA-based therapeutic development in Singapore

Everest Medicines Announces Acceptance of the New Drug Application for VELSIPITY

You may like
More>>

Chinese mainland reports 39 locally transmitted COVID-19 cases

Related News

Corvia Medical Achieves CE Certification for Atrial Shunt Under New EU MDR Standards

Macrogen Consortium win tender for National Bio Big Data Project

SCG Cell Therapy partners A*STAR to accelerate RNA-based therapeutic development in Singapore

Everest Medicines Announces Acceptance of the New Drug Application for VELSIPITY

You may likeMore>>

You may like
More>>